
    On Thursday, June 13, 2013, the President signed into law:
S. 622, the "Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013", which reauthorizes the collection and spending of user fees by the Food and Drug Administration for brand-name and generic animal drugs.
  